chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 9pm, I started to experience headaches, dizziness and nauseated. The headaches are to my temples and to the back of my head with inflammation on my head.  The next day I went to see my PCP in the early afternoon because my blood pressure. My blood pressure readings 140/70, 166/76, 144/80 and 161/89. My doctor put me on BP medication, Metoprolol to take for a few days. I also experienced jaw pain and I went to the dentist where an x-ray was done, which was negative. I was also put on antibiotics due to a suspected middle ear infection. I felt like I had a spiral headache.  I saw my PCP, nurse practitioner who gave me a steroid injection which helped. I have cancelled my second dose injection. I have been sick for 4 weeks. I still have the jaw pain with a ringing sensation to my left ear.  Tomorrow I will go get more tests done. I am also having swollen neck with lymph nodes swollen.
I recently began monitoring my blood pressure at home with an Omron Platinum series monitor. On the morning of Wednesday, April 7, I received a reading of an irregular heartbeat. I also received a reading of an irregular heartbeat on the evening of April 7, the morning of April 8, the evening of April 8, and the evening of April 9. I reported this information to my doctor who suggested I wear a Holter monitor for 48 hours to see if I had any issues with my heart. The result of the Holter monitor showed that I am having PVCs less than 1% of the time. Since I got so many readings of irregular heartbeat in a short amount of time on my monitor, I thought the irregular heartbeats may be related to the vaccine which was administered the afternoon before I began getting the irregular heartbeat notifications.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.     On 27-Mar-2021 at 1:12 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 1:12 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  On 27-Mar-2021, Excursion time was 9A, temperature was 35, total doses given for the day was 195, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 20 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Pt called today stating that she had severe chills that kept her up at night and also a severe headache.
Diarrhea, Tachycardia,  +LIGHTHEADEDNESS +ELEVATED BP EXTREMITIES FELT COLD, NUMB AND TINGLY  Narrative:  ER Impression: Minor Allergic Reaction History of anxiety w/ panic PVC's on telemetry monitoring Anisecoria (slightly unequal pupils)
Sudden loss of strength in legs.  General weakness.. improved the next day. Happened worse with second dose.  Felt myself losing strength in my legs lowered myself to the ground and crawl to a chair. Didn?t have enough strength to push up from the chair. Managed to get in bed but couldn?t move  Improved by the next morning
Heavy mucous production; Low grade fever; Felt achy; This spontaneous case was reported by a consumer and describes the occurrence of SECRETION DISCHARGE (Heavy mucous production), PYREXIA (Low grade fever) and MYALGIA (Felt achy) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Hypertension.    On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Felt achy). On 14-Feb-2021, the patient experienced SECRETION DISCHARGE (Heavy mucous production) and PYREXIA (Low grade fever). At the time of the report, SECRETION DISCHARGE (Heavy mucous production) and PYREXIA (Low grade fever) outcome was unknown and MYALGIA (Felt achy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were high blood pressure medicine, inhaler for seasonal allergies. Treatment details included paracetamol.
This spontaneous report was received from a healthcare worker referring to two unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions, drug and allergy history were not reported. On 22-JAN-2016 and on 09-MAR-2016 the patients were vaccinated with improperly stored injections of RECOMBIVAX HB, lot # K021444 and expiration date 17-SEP-2016 (strength, dose number and route of administration were not provided) for prophylaxis. The patients' concomitant therapies were not reported. The vaccines were exposed to two different temperature excursion, first on 29-DEC-2015, exposed to temperature ranges between 32° Fahrenheit (F) and 35°F  (34.3° F) during a time frame of 22 hours 30 minutes, and on 04-FEB-2016, exposed to temperature ranges between 47°F and 77°F (50°F) during a time frame of 1 hour 30 minutes. The temperature excursions were called by a data logger, there was not previous temperature excursion. Adverse effects were not reported. This is one of two reports received from the same source.; Sender's Comments: US-009507513-1706USA005017:
New neuropathy in hands and feet almost immediately after vaccine administered. Painful neuropathy particularly in fingertips making minor tasks excruciating. Periods stopped for three months. Increased edema. Increased memory loss, fatigue, Headaches have doubled or tripled. Frequent migraines. Hands clench into fists involuntarily and fingers lock up.  Extreme body aches; joints painful. First shot did not have many side effects. Have had dramatic increase in inflammatory symptoms after second shot. Essentially all of my preexisting autoimmune issues were exacerbated after the second shot.
my blood oxygen was perhaps a point or two lower than my normal readings (95%-98%) for a few days.; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; I woke up feeling like I had a awful case of the flu: Muscle weakness, gait instability, temp 101.2F. Vomited once. No diarrhea.  One day later I felt much better: My temperature subsided over the next 3 days to normal, and all the other symptoms dis; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 75-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8727 and expiry date: unknown), dose 2 via an unspecified route of administration, administered in Arm Right on 19Mar2021 at 13:00 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included glucose tolerance impaired, drug hypersensitivity. The patient's concomitant medications were not reported. The patient received dose 1 of bnt162b2 on 24-FEB-2021 for Covid-19 immunisation (vaccine location: Right arm). The patient experienced my blood oxygen was perhaps a point or two lower than my normal readings (95%-98%) for a few days, i woke up feeling like i had a awful case of the flu: muscle weakness, gait instability, temp 101.2f. vomited once. no diarrhea.  one day later i felt much better: my temperature subsided over the next 3 days to normal, and all the other symptoms dis, on 10Apr2021 at 12:00. Laboratory test includes body temperature: 101.2 fahrenheit, oxygen saturation: 95%-98%, sars-cov-2 antibody test negative: negative. The event resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received by the patient. Outcome of the events was recovered on an unknown date.  No follow-up attempts are possible. No further information is expected.
Acute joint pain. Hands/fingers/knees could not hardly bend. (constant throbbing pain). Acute pain lasted 24 hours - took Excedrin and used heat to try to get comfortable. Headache and body ache like the flu - lasted 24 hours. After that day, knees and hands/finger joints continued to ache (felt like needles sticking in the joints) continued off and on. Still having this on and off- but not quite as bad. Take Excedrin or Tylenol to help alleviate the pain.
Information has been received from a physician concerning an approximately 12 month old male who on 19-MAR-2010 was vaccinated with a dose of MMR II. Secondary suspect therapy included VARIVAX (MSD) and VAQTA (MSD). Other concomitant therapy included DTaP and PREVNAR. Around nine to ten days after vaccination, on approximately 29-MAR-2010 the patient experienced a low grade fever and rash. The physician believed it was a mild case of either measles or rubella because it did not look like varicella. At the time of the report, the outcome was unknown. Additional information has been requested. This is one of two reports received from the same source.
On 9/7/00, the pt experienced coughing, could not breath. The pt went to the ER on 9/10/00 with coughing and blueness. The pt was admitted with a positive test for pertussis.
started on morning of 12SEP93; had shrill scream & went on for most of day; stopped 10-11Pm that noc;
high fever & febrile seizure; approx 36 hrs p/office visit & receiving vax;
Vomiting, dehydration, had intussusception reduced with air enema. 06/20/07-records received for DOS 4/28-4/29/07-Impression:Ileocolic Intussusception status post air enema reduction. Complaint of vomiting for 7 hours and has vomited 4 times day of admission. No diarrhea. No abdominal pain. Returned to ER with 2 days of vomiting and decreased PO intake. Sleepy, decreased response level.
6 hours after receiving the vaccine I developed a sore arm & severe headache, later followed by chills, all over body aches, severe fatigue, nausea, diarrhea, and then a fever of 102.1 which lasted three days and did not break or go down with Tylenol. On the third day I had no symptoms at all other than slight fatigue.
Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Moderna Covid-19 Vaccine, Bivalent 0.25mL, instead of 0.5mL to given adult patients).    No concomitants product information reported.  It was reported that they had administered patient the Moderna COVID-19 Bivalent 0.25mL, instead of 0.5mL to adult patient.  No treatment product information reported.  This case was for patient 4 of 9 patients reported.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 15-JUL-2016 the patient was vaccinated with an expired dose of ZOSTAVAX (19400 PFU, lot #K020185, expiry date 27-JAN-2016, dose unknown) subcutaneously. No adverse effect was reported. Additional information has been requested.
Information has been received concerning a pt who was vaccinated on 11/14/95 with one dose of varicella vaccine. On 06/11/00, the pt developed breakthrough chickenpox with 20-30 lesions, some of which were vesicular. The physician had collected a specimen. The pt sought unspecified medical attention. Follow up information received on 06/26/00 from a physician, indicated that the pt was afebrile throughout the breakout of approximately 30 lesions, mostly small red papules but with some barely scabbed but rather melted away. The physician indicated that she did a gptiter and the child was positive. Follow up information received on 07/03/00 from a woman at Columbia University indicated that the swab of vesicular fluid was negative for VZV and preliminary results from a scab sent is VZV positive wild type. Follow up information received on 09/05/2000 from a physician indicated that a varicella EIA was positive prior to lesions. Fifty papules with vesicles were noted on the pt's nose and back.
Patient was given a 0.5ml dose Moderna monovalent vaccine 50mcg/0.5ml instead of the Moderna bivalent covid vaccine
Pt c/o being light headed, BP 80/50, P 64, RR 16, Color good, lung sounds clear, no stridor feels her tongue is heavy, this is not visibly swollen, denies chest pain/tightness. Pt placed flat/supine, 911 called, arrival of Paramedic transported to medical center. Pt states through an interpreter that she had peptic ulcers and ran out of meds at 2 weeks ago. This past week she had been vomiting blood.
Swelling & redness to right eyelid, swelling, burning & itching to the inside of mouth, scalp & palms of both hands
This is a spontaneous report from a contactable consumer reporting on behalf of her son. A 13-year-old male patient received the first dose of TRUMENBA via an unspecified route of administration in the right on 15MAY2015 at around 4:45 PM at 0.5 ml single. No medical history, concomitant medications and relevant tests were reported. The patient experienced pain at injection site on 15MAY2015 at around 7 PM. The patient recovered on an unspecified date in MAY2015. According to the patient mother he would continue with the series of immunization. Follow-up (25JUN2015): Follow-up attempts completed. No further information expected.
The Physician reported 11-day old patient received GARDASIL 9 today.; No adverse effects reported.; This spontaneous report was received from a physician referring to an 11 day old patient. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.      On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9)(strength, route, dose, frequency, anatomical location, lot # and expiration date were unknown) for prophylaxis. No adverse events were reported.
Patient developed pain in the deltoid muscle after the vaccination. Pain persistent as of date of this report (3/8). No findings on exam.
Arrived at motel for vacation Thanksgiving and had issues walking to room. Felt very weak and never felt right. Cut short five day stay and went home. Thought it was touch of flu and continued pre-planned travel thinking she'd feel better.
Unexplained rash (treatment non-responsive). Rash began days after 2nd Moderna vaccine and have gotten worse. Rash spread from groin, to flank, to back
Starting 1 week after receiving the vaccine, I developed swelling, heat and a large hard lump at the injection site. I saw a doctor via telehealth and they said it was likely a delayed reaction. I was told to put a circle around it and to give her a callback if it increased (but didn't). Also, I was instructed to use an ice pack and take some Tylenol, and give it a few days. So, I took some Tylenol and after a few days it went away.
Patient reports elevated blood glucose readings into the "200's," shortness of breath and fatigue within 24 hours of receiving the Pfizer COVID-19 vaccine.
Information has been received from a health professional concerning a 3 year old female who on 28-DEC-2004 was vaccinated, 0.5mL subcutaneously, first dose, with varicella virus vaccine live (Oka/Merck) (lot#647715/0190P). On 15-May it was reported, "the patient had lesions on her face, around her mouth, and sporadic lesions all over her body." On 16-MAY-2007, the patient's mother reported this to the physician. The patient's chickenpox persisted. Follow-up information received by the health care professional indicated that the patient is a 3 year old female, 36 lbs., and 37.5 inches tall. The patient also received Prevnar (lot# A74404K) at the same time in the left thigh. She received 2 previous doses of Prevnar. On 16-May-2007 (previously reported as 15-May-2007), the patient presented with rash around mouth-rare-red occasional at other spots on the body. Patient was also itchy. Diagnosis was varicella and pharyngitis. There was no illness at the time of vaccination and no pre-existing allergies, birth defects or medical conditions. Informed consent was obtained. Additional information has been requested.
Patient indicated that she had a stroke the evening of 5/4/2021 after she received the Janssen Covid 19 Vaccination.
pt recv 1dose of varivax 6/30/97. 5/13/98 pt was dx w/shingles. 5/14 pt worsened & MD rpt pt had red, vesicular rash & 3 patches of lesions & vesicles on la only.
Patient called the office 1 day post injection (Friday) stating that her (R) arm was red, hot and swollen from the elbow up to the clavicle. Also very painful. When called to follow up Monday morning pt was still c/o pain but all other sx cleared on Sunday.
This consumer reported similar events for two patients. This is the second of two reports. This is a spontaneous report from a contactable consumer via a Pfizer sales representative. A 4-year-old male patient received a dose of PREVNAR 13 on the right thigh on an unspecified date. Relevant medical history was unknown. Concomitant vaccines on the same day included Varicella Virus Vaccine, Live and Hepatitis A Vaccine on the left thigh. On 01Apr2011, the patient developed swelling and redness at the site of injection on the right thigh. On 04Apr2011, the swelling and redness at the injection site turned into cellulitis. Therapeutic measures taken as a result of cellulitis included treatment with SEPTRA, BENADRYL, cold compression therapy and ibuprofen. Relevant lab data was unknown. The patient had not recovered from the events at the time of this report.
Mom reports she noticed hives on baby's back; Buttocks at 8 PM on 5/27/09 - approximately 4 hours after injection - and a fever of 99.9 gone by noon next day.
Tired; Body aches; Night sweats; Nausea; Headache; Dizzy; chills; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 30Mar2021 at 10:15(at the age of 48-year-old) as a dose2, single for COVID-19 immunization. No relevant medical history. The patient did not have any allergies to medications, food, or other products. The patient received other medications within two weeks of vaccination which are unspecified. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 06Mar2021 at 12:30(at the age of 48-year-old) as a dose1, single for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 23:15, approximately 13 hours after 2nd dose, she had night sweats, nausea and headache. she was also dizzy. Then she had chills. This lasted approximately 4-5 hours off and on. The symptoms subsided gradually. On 31Mar2021 she was tired and had body aches for another 18 hours. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event night sweats, nausea, headache, dizzy was recovered in 2021. The clinical outcome of the event chills was recovered on an unspecified date in Mar2021. The clinical outcome of the event tired body aches was recovered on 01Ap2021.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: 1.  For event Tired and Body aches, Event onset date updated to 01-Apr-2021 01:30, stop date updated to 01-Apr-2021 19:30.  For event chills, Event top date field warning justification was checked.